Biological Drug Api Manufacturing Market Report

Biological Drug Api Manufacturing Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Nov 24, 2019
  • PAGES：194
  • REPORT CODE：GMM392148
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Biological Drug Api Manufacturing market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.9% during the forecast period.

    This report presents the market size and development trends by detailing the Biological Drug Api Manufacturing market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Biological Drug Api Manufacturing market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Biological Drug Api Manufacturing industry and will help you to build a panoramic view of the industrial development.

    Biological Drug Api Manufacturing Market, By Type:

    • Monoclonal antibodies (mAbs)

    • Insulin

    • Vaccines

    • Interferons

    • Human growth hormones

    Biological Drug Api Manufacturing Market, By Application:

    • End-User 1

    • End-User 2

    • End-User 3

    Some of the leading players are as follows:

    • Celltrion

    • Lonza

    • FUJIFILM Diosynth Biotechnologies

    • DSM Biologics

    • Samsung BioLogics

    • Boehringer Ingelheim BioXcellence

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Biological Drug Api Manufacturing Market: Technology Type Analysis

    • 4.1 Biological Drug Api Manufacturing Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Biological Drug Api Manufacturing Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Monoclonal antibodies (mAbs)

      • 4.3.2 Insulin

      • 4.3.3 Vaccines

      • 4.3.4 Interferons

      • 4.3.5 Human growth hormones

    5 Biological Drug Api Manufacturing Market: Product Analysis

    • 5.1 Biological Drug Api Manufacturing Product Market Share Analysis, 2018 & 2026

    • 5.2 Biological Drug Api Manufacturing Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Biological Drug Api Manufacturing Market: Application Analysis

    • 6.1 Biological Drug Api Manufacturing Application Market Share Analysis, 2018 & 2026

    • 6.2 Biological Drug Api Manufacturing Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 End-User 1

      • 6.3.2 End-User 1

      • 6.3.3 End-User 3

    7 Biological Drug Api Manufacturing Market: Regional Analysis

    • 7.1 Biological Drug Api Manufacturing Regional Market Share Analysis, 2018 & 2026

    • 7.2 Biological Drug Api Manufacturing Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Celltrion

      • 9.1.1 Celltrion Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Lonza

      • 9.2.1 Lonza Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 FUJIFILM Diosynth Biotechnologies

      • 9.3.1 FUJIFILM Diosynth Biotechnologies Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 DSM Biologics

      • 9.4.1 DSM Biologics Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Samsung BioLogics

      • 9.5.1 Samsung BioLogics Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Boehringer Ingelheim BioXcellence

      • 9.6.1 Boehringer Ingelheim BioXcellence Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

     

    The List of Tables and Figures (Totals 111 Figures and 145 Tables)

    • Figure Monoclonal antibodies (mAbs) Biological Drug Api Manufacturing market, 2015 - 2026 (USD Million)

    • Figure Insulin Biological Drug Api Manufacturing market, 2015 - 2026 (USD Million)

    • Figure Vaccines Biological Drug Api Manufacturing market, 2015 - 2026 (USD Million)

    • Figure Interferons Biological Drug Api Manufacturing market, 2015 - 2026 (USD Million)

    • Figure Human growth hormones Biological Drug Api Manufacturing market, 2015 - 2026 (USD Million)

    • Figure End-User 1 market, 2015 - 2026 (USD Million)

    • Figure End-User 2 market, 2015 - 2026 (USD Million)

    • Figure End-User 3 market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Biological Drug Api Manufacturing market, by country, 2015 - 2026 (USD Million)

    • Table North America Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table North America Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table North America Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table Canada Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table Canada Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Europe Biological Drug Api Manufacturing market, by country, 2015 - 2026 (USD Million)

    • Table Europe Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table Europe Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table Europe Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table Germany Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table Germany Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table France Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table France Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table Italy Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table Italy Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table Spain Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table Spain Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Biological Drug Api Manufacturing market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table China Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table China Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table Japan Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table Japan Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table India Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table India Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Biological Drug Api Manufacturing market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table MEA Biological Drug Api Manufacturing market, by country, 2015 - 2026 (USD Million)

    • Table MEA Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table MEA Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table MEA Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Biological Drug Api Manufacturing market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Biological Drug Api Manufacturing market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Biological Drug Api Manufacturing market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Celltrion Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Lonza Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table FUJIFILM Diosynth Biotechnologies Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table DSM Biologics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Samsung BioLogics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Boehringer Ingelheim BioXcellence Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US